For: | Wang HC, Huang X, Chen J, Li Y, Cong Y, Qu BL, Feng SQ, Liu F. Long-term efficacy and predictors of pembrolizumab-based regimens in patients with advanced esophageal cancer in the real world. World J Gastroenterol 2023; 29(41): 5641-5656 [PMID: 38077159 DOI: 10.3748/wjg.v29.i41.5641] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i41/5641.htm |
Number | Citing Articles |
1 |
Kazumasa Yamamoto, Shun Yamamoto, Ken Kato. Pembrolizumab for recurrent locally advanced or metastatic squamous cell carcinoma of the esophagus: a drug safety evaluation. Expert Opinion on Drug Safety 2024; 23(6): 667 doi: 10.1080/14740338.2024.2348554
|